Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001604867-24-000018
Filing Date
2024-11-14
Accepted
2024-11-14 15:18:30
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 8185
2 mura_ex1.pdf EX-1 47879
  Complete submission text file 0001604867-24-000018.txt   76096
Mailing Address 1063 POST ROAD 2ND FLOOR DARIEN CT 06820
Business Address 1063 POST ROAD 2ND FLOOR DARIEN CT 06820 203-625-1300
Solas Capital Management, LLC (Filed by) CIK: 0001604867 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G

Mailing Address 10 EARLSFORT TERRACE DUBLIN 2 L2 D02 T380
Business Address 10 EARLSFORT TERRACE DUBLIN 2 L2 D02 T380 353 1 905 8020
Mural Oncology plc (Subject) CIK: 0001971543 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-94252 | Film No.: 241460871
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)